NL-OMON26330尚未招募不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing
Prof. dr. J.B.L. HoekstraDept. of Internal MedicineAcademic Medical Centre0 个研究点目标入组 140 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 140
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age > 18 years
- •2. Diagnosis of type 2 diabetes
排除标准
- •1. Current acetylsalicylic acid therapy
- •2. Use of any medication interfering with platelet function, e.g. diclofenac, naproxen or clopidogrel in the two weeks prior to the study.
研究者
相似试验
进行中（未招募）
不适用
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosing - ASSIGType 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-001308-22-NLAcademic Medical Centre
尚未招募
4 期
Aspirin sensitivity in diabetes mellitus; the role of glycaemic control and dosingdiabetes mellitusNL-OMON31925Academisch Medisch Centrum140
已完成
不适用
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic PatientsDiabetes Mellitus, Type IINCT00649909Hadassah Medical Organization18
Unknown
3 期
Aspirin and Renal Disease Progression in Patients With Type 2 DiabetesDiabetesNCT02895113University of Roma La Sapienza418
已完成
4 期
Aspirin Dosing in Diabetic PatientsType 2 Diabetes MellitusCoronary Artery DiseaseNCT01201785University of Florida20